R&D DAYS 1/5: IR Conference Call on Phase 2b BTKi (‘168) Trial Results
Sanofi hosted on April 23, 2020 a live webcast and conference call on the detailed Phase 2b results of the investigational BTK inhibitor ('168) in relapsing multiple sclerosis.
Highlights
Sanofi hosted on April 23, 2020 a live webcast and conference call on the detailed Phase 2b results of the investigational BTK inhibitor ('168) in relapsing multiple sclerosis. (16h00 CET / 10:00am ET)